IP Verse

Sanofi Biotechnology vs. Amgen - UPC_COA_641/2025

The UPC Case UPC_COA_641/2025 was filed on 14 Jul, 2025 by the plaintiff Sanofi Biotechnology against the defendant Amgen.

Case Details

    Case Number:

    UPC_COA_641/2025

    Patent Number:

    EP3536712

    Filing Date:

    14 Jul, 2025

    Proceeding Type:

    Appeal

    Case Phase:

    Written Phase

    Plaintiffs:

    • Sanofi Biotechnology

    Plaintiff Representatives:

    • Niels HOELDER

    Defendants:

    • Amgen

    Defendant Representatives:

    • Johannes HESELBERGER

    Judges:

    • Cornelis Schüller
    • Ingeborg Simonsson
    • Patricia Rombach
    • Rainer Friedrich
    • Rian Kalden

Case Decision

Decision pending - set alert to receive updates

Docket Entries

The docket entries provide a comprehensive overview of all filings, motions, orders, and other significant actions taken in the case.

DateTitleLink
Sep 18, 2025Panel Appointment-
Sep 18, 2025Acknowledgement Of Lodging-
Sep 16, 2025Exhibit He 124-
Sep 16, 2025Exhibit He 123-
Sep 16, 2025Exhibit He 122-
Sep 16, 2025Exhibit He 121-
Sep 16, 2025Exhibit He 120-
Sep 16, 2025Exhibit He 119-
Sep 16, 2025Exhibit He 118-
Sep 16, 2025Exhibit He 117-
Sep 16, 2025Acknowledgement Of Lodging-
Sep 16, 2025.09.15 Grounds Of Appeal-
Sep 10, 2025Order On Stay
Sep 4, 2025Exhibit Bp86 Amgen-
Sep 4, 2025Appeal Comments To Orders Amgen En-
Aug 28, 2025.08.28 Sanofi Regeneron Comments On Possibility Of A Stay Signed-
Aug 22, 2025Case Management Order-
Jul 15, 2025Receipt-
Jul 15, 2025Panel Appointment-
Jul 15, 2025Formal Checks Notification Of Positive Outcome-
Jul 14, 2025Proof Of Payment-
Jul 14, 2025Acknowledgement Of Lodging-
Jul 14, 2025.07.14 EP712Statement Of Appeal Signed-
Sep 18, 2025Panel Appointment-
Sep 18, 2025Acknowledgement Of Lodging-
Sep 16, 2025Exhibit He 124-
Sep 16, 2025Exhibit He 123-
Sep 16, 2025Exhibit He 122-
Sep 16, 2025Exhibit He 121-
Sep 16, 2025Exhibit He 120-
Sep 16, 2025Exhibit He 119-
Sep 16, 2025Exhibit He 118-
Sep 16, 2025Exhibit He 117-
Sep 16, 2025Acknowledgement Of Lodging-
Sep 16, 2025.09.15 Grounds Of Appeal-
Sep 10, 2025Order On Stay
Sep 4, 2025Exhibit Bp86 Amgen-
Sep 4, 2025Appeal Comments To Orders Amgen En-
Aug 28, 2025.08.28 Sanofi Regeneron Comments On Possibility Of A Stay Signed-
Aug 22, 2025Case Management Order-
Jul 15, 2025Receipt-
Jul 15, 2025Panel Appointment-
Jul 15, 2025Formal Checks Notification Of Positive Outcome-
Jul 14, 2025Proof Of Payment-
Jul 14, 2025Acknowledgement Of Lodging-
Jul 14, 2025.07.14 EP712Statement Of Appeal Signed-
Sep 18, 2025Panel Appointment-
Sep 18, 2025Acknowledgement Of Lodging-
Sep 16, 2025Exhibit He 124-
Sep 16, 2025Exhibit He 123-
Sep 16, 2025Exhibit He 122-
Sep 16, 2025Exhibit He 121-
Sep 16, 2025Exhibit He 120-
Sep 16, 2025Exhibit He 119-
Sep 16, 2025Exhibit He 118-
Sep 16, 2025Exhibit He 117-
Sep 16, 2025Acknowledgement Of Lodging-
Sep 16, 2025.09.15 Grounds Of Appeal-
Sep 10, 2025Order On Stay
Sep 4, 2025Exhibit Bp86 Amgen-
Sep 4, 2025Appeal Comments To Orders Amgen En-
Aug 28, 2025.08.28 Sanofi Regeneron Comments On Possibility Of A Stay Signed-
Aug 22, 2025Case Management Order-
Jul 15, 2025Receipt-
Jul 15, 2025Panel Appointment-
Jul 15, 2025Formal Checks Notification Of Positive Outcome-
Jul 14, 2025Proof Of Payment-
Jul 14, 2025Acknowledgement Of Lodging-
Jul 14, 2025.07.14 EP712Statement Of Appeal Signed-
Sep 18, 2025Panel Appointment-
Sep 18, 2025Acknowledgement Of Lodging-
Sep 16, 2025Exhibit He 124-
Sep 16, 2025Exhibit He 123-
Sep 16, 2025Exhibit He 122-
Sep 16, 2025Exhibit He 121-
Sep 16, 2025Exhibit He 120-
Sep 16, 2025Exhibit He 119-
Sep 16, 2025Exhibit He 118-
Sep 16, 2025Exhibit He 117-
Sep 16, 2025Acknowledgement Of Lodging-
Sep 16, 2025.09.15 Grounds Of Appeal-
Sep 10, 2025Order On Stay
Sep 4, 2025Exhibit Bp86 Amgen-
Sep 4, 2025Appeal Comments To Orders Amgen En-
Aug 28, 2025.08.28 Sanofi Regeneron Comments On Possibility Of A Stay Signed-
Aug 22, 2025Case Management Order-
Jul 15, 2025Receipt-
Jul 15, 2025Panel Appointment-
Jul 15, 2025Formal Checks Notification Of Positive Outcome-
Jul 14, 2025Proof Of Payment-
Jul 14, 2025Acknowledgement Of Lodging-
Jul 14, 2025.07.14 EP712Statement Of Appeal Signed-
Sep 18, 2025Panel Appointment-
Sep 18, 2025Acknowledgement Of Lodging-
Sep 16, 2025Exhibit He 124-
Sep 16, 2025Exhibit He 123-
Sep 16, 2025Exhibit He 122-
Sep 16, 2025Exhibit He 121-
Sep 16, 2025Exhibit He 120-
Sep 16, 2025Exhibit He 119-
Sep 16, 2025Exhibit He 118-
Sep 16, 2025Exhibit He 117-
Sep 16, 2025Acknowledgement Of Lodging-
Sep 16, 2025.09.15 Grounds Of Appeal-
Sep 10, 2025Order On Stay
Sep 4, 2025Exhibit Bp86 Amgen-
Sep 4, 2025Appeal Comments To Orders Amgen En-
Aug 28, 2025.08.28 Sanofi Regeneron Comments On Possibility Of A Stay Signed-
Aug 22, 2025Case Management Order-
Jul 15, 2025Receipt-
Jul 15, 2025Panel Appointment-
Jul 15, 2025Formal Checks Notification Of Positive Outcome-
Jul 14, 2025Proof Of Payment-
Jul 14, 2025Acknowledgement Of Lodging-
Jul 14, 2025.07.14 EP712Statement Of Appeal Signed-

More cases involving EP3536712B1

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Oct 9, 2025
Case NumberFiling DatePlaintiffsDefendants
APL_32715/2025Jul 14, 2025Regeneron Pharmaceuticals, Sanofi BiotechnologiesAmgen, Amgen Europe
APL_32765/2025Jul 11, 2025Amgen, Amgen EuropeRegeneron Pharmaceuticals
UPC_COA_646/2025Jul 11, 2025AmgenRegeneron Pharmaceuticals

More cases involving Sanofi Biotechnology

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Oct 9, 2025
Case NumberFiling DatePlaintiffsDefendants
App_34318/2025Aug 5, 2025Sanofi Biotechnology -
App_33251/2025Jul 21, 2025Sanofi Biotechnology -
App_27318/2025Jun 10, 2025Sanofi Biotechnology -

More cases involving Amgen

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Oct 9, 2025
Case NumberFiling DatePlaintiffsDefendants
App_35200/2025Aug 21, 2025Amgen, Amgen AB, Amgen Biofarmaceutica LDA, Amgen Technology Ireland Unlimited, Amgen Zdravila DOO -
App_35086/2025Aug 20, 2025Amgen, Amgen AB, Amgen Biofarmaceutica LDA, Amgen Technology Ireland Unlimited, Amgen Zdravila DOO -
App_35087/2025Aug 20, 2025Amgen, Amgen AB, Amgen Biofarmaceutica LDA, Amgen Technology Ireland Unlimited, Amgen Zdravila DOO -